Literature DB >> 20807269

Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function.

Sarah Juel Paulsen1, Niels Vrang, Leif Kongskov Larsen, Philip Just Larsen, Jacob Jelsing.   

Abstract

The present study was initiated to improve our understanding of pancreatic beta-cell dynamics in male Zucker Diabetic Fatty (ZDF) rats and hence provide a framework for future diabetes studies in this animal model. Male ZDF rats from 6, 8, 10, 12, 14, 16, 20 and 26 weeks of age were subjected to an oral glucose tolerance test (OGTT). The animals were then euthanized and pancreases were removed for morphometric analyses of pancreatic beta-cell mass. As evident by a marked fourfold increase in insulin secretion, insulin resistance developed rapidly from 6 to 8 weeks of age. Simultaneously, the pancreatic beta-cell mass expanded from 6.17 ± 0.41 mg at 6 weeks of age, reaching a maximum of 16.5 ± 2.5 mg at 16 weeks of age, at which time pancreatic beta-cell mass gradually declined. The corresponding changes in glucose/insulin homeostasis were analysed using a standard insulin sensitivity index (ISI), an area under the curve (AUC) glucose-insulin index, or simple semi-fasted glucose levels. The study demonstrated that male ZDF rats underwent rapid changes in pancreatic beta-cell mass from the onset of insulin resistance to frank diabetes coupled directly to marked alterations in glucose/insulin homeostasis. The study underscores the need for a critical co-examination of glucose homeostatic parameters in studies investigating the effects of novel anti-diabetic compounds on pancreatic beta-cell mass in the male ZDF rat. A simple assessment of fasting glucose levels coupled with information about age can provide a correct indication of the actual pancreatic beta-cell mass and the physiological state of the animal.
© 2010 Rheoscience A/S. Journal of Anatomy © 2010 Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807269      PMCID: PMC3035867          DOI: 10.1111/j.1469-7580.2010.01285.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  24 in total

1.  Increased islet volume but unchanged islet number in ob/ob mice.

Authors:  Troels Bock; Bente Pakkenberg; Karsten Buschard
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

2.  In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.

Authors:  S W Janssen; G J Martens; C G Sweep; H A Ross; A R Hermus
Journal:  Horm Metab Res       Date:  1999-11       Impact factor: 2.936

3.  The efficiency of systematic sampling in stereology and its prediction.

Authors:  H J Gundersen; E B Jensen
Journal:  J Microsc       Date:  1987-09       Impact factor: 1.758

4.  A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat.

Authors:  S C Griffen; J Wang; M S German
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

5.  Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.

Authors:  S W Janssen; A R Hermus; W P Lange; Q Knijnenburg; J A van der Laak; C G Sweep; G J Martens; A A Verhofstad
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

6.  Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.

Authors:  D T Finegood; M D McArthur; D Kojwang; M J Thomas; B G Topp; T Leonard; R E Buckingham
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

Review 7.  Glucagon-like peptide-1, glucose homeostasis and diabetes.

Authors:  Jens J Holst; Carolyn F Deacon; Tina Vilsbøll; Thure Krarup; Sten Madsbad
Journal:  Trends Mol Med       Date:  2008-03-18       Impact factor: 11.951

8.  Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.

Authors:  Wissal El-Assaad; Jean Buteau; Marie-Line Peyot; Christopher Nolan; Raphael Roduit; Serge Hardy; Erik Joly; Ghassan Dbaibo; Lawrence Rosenberg; Marc Prentki
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

9.  Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.

Authors:  Robert E Schmidt; Denise A Dorsey; Lucie N Beaudet; Richard G Peterson
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

Authors:  Roberto Lupi; Francesco Dotta; Lorella Marselli; Silvia Del Guerra; Matilde Masini; Carmela Santangelo; Giovanni Patané; Ugo Boggi; Salvatore Piro; Marcello Anello; Ettore Bergamini; Franco Mosca; Umberto Di Mario; Stefano Del Prato; Piero Marchetti
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

View more
  18 in total

Review 1.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

2.  Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.

Authors:  M Feigh; K V Andreassen; A V Neutzsky-Wulff; S T Petersen; C Hansen; A C Bay-Jensen; J E Henriksen; H Beck-Nielsen; C Christiansen; K Henriksen; M A Karsdal
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

4.  Stereological estimation and morphological assessment of the endocrine pancreatic components in relation to sex in hen.

Authors:  Rahmat Allah Fatahian Dehkordi; Hamid Moradi
Journal:  Vet Res Forum       Date:  2015-03-15       Impact factor: 1.054

5.  Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes.

Authors:  Leif E Johnson; Michael Larsen; Maria-Thereza Perez
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

6.  Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats.

Authors:  Bethany P Cummings; Ahmed Bettaieb; James L Graham; Jaehyoung Kim; Fangrui Ma; Noreene Shibata; Kimber L Stanhope; Cecilia Giulivi; Frederik Hansen; Jacob Jelsing; Niels Vrang; Mark Kowala; Michael L Chouinard; Fawaz G Haj; Peter J Havel
Journal:  Dis Model Mech       Date:  2012-12-20       Impact factor: 5.758

7.  VHL-mediated disruption of Sox9 activity compromises β-cell identity and results in diabetes mellitus.

Authors:  Sapna Puri; Haruhiko Akiyama; Matthias Hebrok
Journal:  Genes Dev       Date:  2013-12-01       Impact factor: 11.361

8.  Characterisation of age-dependent beta cell dynamics in the male db/db mice.

Authors:  Louise S Dalbøge; Dorthe L C Almholt; Trine S R Neerup; Efstathios Vassiliadis; Niels Vrang; Lars Pedersen; Keld Fosgerau; Jacob Jelsing
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

Review 9.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03

10.  Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo.

Authors:  Carol T Bussey; Anne E de Leeuw; Regis R Lamberts
Journal:  Cardiovasc Diabetol       Date:  2014-12-10       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.